Ai-Bee Ong

421 total citations
5 papers, 330 citations indexed

About

Ai-Bee Ong is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Ai-Bee Ong has authored 5 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Oncology, 2 papers in Pharmacology and 1 paper in Molecular Biology. Recurrent topics in Ai-Bee Ong's work include Pharmacogenetics and Drug Metabolism (2 papers), Angiogenesis and VEGF in Cancer (1 paper) and Radiomics and Machine Learning in Medical Imaging (1 paper). Ai-Bee Ong is often cited by papers focused on Pharmacogenetics and Drug Metabolism (2 papers), Angiogenesis and VEGF in Cancer (1 paper) and Radiomics and Machine Learning in Medical Imaging (1 paper). Ai-Bee Ong collaborates with scholars based in Singapore, Australia and United States. Ai-Bee Ong's co-authors include Boon-Cher Goh, Soo Chin Lee, Lu Fan, Lingzhi Wang, How-Sung Lee, Jiayi Guo, Erin G. Schuetz, Robert C. Lim, Jatinder K. Lamba and Wei Peng Yong and has published in prestigious journals such as Journal of Clinical Oncology, Acta Oncologica and Therapeutic Drug Monitoring.

In The Last Decade

Ai-Bee Ong

5 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ai-Bee Ong Singapore	4	222	126	104	66	43	5	330
Martin A. Graham United States	8	174 0.8×	92 0.7×	208 2.0×	30 0.5×	22 0.5×	17	412
W. Messersmith United States	5	206 0.9×	55 0.4×	96 0.9×	87 1.3×	35 0.8×	9	302
Sonya C. Tate United Kingdom	8	340 1.5×	133 1.1×	115 1.1×	140 2.1×	84 2.0×	9	474
Noelia Nebot United States	11	164 0.7×	46 0.4×	180 1.7×	62 0.9×	22 0.5×	17	432
Sravanthi Cheeti United States	12	184 0.8×	73 0.6×	293 2.8×	58 0.9×	50 1.2×	28	522
Agneta Freijs Sweden	8	249 1.1×	67 0.5×	85 0.8×	25 0.4×	14 0.3×	9	368
Carolyn J. Bowen United States	10	215 1.0×	36 0.3×	132 1.3×	70 1.1×	34 0.8×	14	401
Valerie D. Doodeman Netherlands	11	424 1.9×	159 1.3×	295 2.8×	113 1.7×	39 0.9×	12	632
C. Tyler Kirkland United States	4	108 0.5×	44 0.3×	85 0.8×	53 0.8×	34 0.8×	6	292
Sarah Troutman United States	8	169 0.8×	43 0.3×	173 1.7×	91 1.4×	30 0.7×	13	362

Countries citing papers authored by Ai-Bee Ong

Since Specialization

Citations

This map shows the geographic impact of Ai-Bee Ong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ai-Bee Ong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ai-Bee Ong more than expected).

Fields of papers citing papers by Ai-Bee Ong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ai-Bee Ong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ai-Bee Ong. The network helps show where Ai-Bee Ong may publish in the future.

Co-authorship network of co-authors of Ai-Bee Ong

This figure shows the co-authorship network connecting the top 25 collaborators of Ai-Bee Ong. A scholar is included among the top collaborators of Ai-Bee Ong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ai-Bee Ong. Ai-Bee Ong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Soo, Ross A., Septian Hartono, Choon Hua Thng, et al.. (2009). Phase I and Biomarker Study of ABT-869, a Multiple Receptor Tyrosine Kinase Inhibitor, in Patients With Refractory Solid Malignancies. Journal of Clinical Oncology. 27(28). 4718–4726. 72 indexed citations

2.

Chuah, Benjamin, Robert Lim, Michael Boyer, et al.. (2007). Multi-centre phase II trial of Thalidomide in the treatment of unresectable hepatocellular carcinoma. Acta Oncologica. 46(2). 234–238. 15 indexed citations

3.

Thng, Choon Hua, Tong San Koh, Helmut Rumpel, et al.. (2007). Dynamic contrast enhanced MRI (DCE MRI) for assessment of effects of anti-angiogenic therapy: Comparison of the transfer constant (Ktrans) to blood flow and permeability derived by a distributed parameters model. Journal of Clinical Oncology. 25(18_suppl). 14109–14109. 1 indexed citations

4.

Lee, How-Sung, Lingzhi Wang, Wei Peng Yong, et al.. (2006). Ketoconazole Renders Poor CYP3A Phenotype Status With Midazolam as Probe Drug. Therapeutic Drug Monitoring. 28(2). 255–261. 10 indexed citations

5.

Goh, Boon-Cher, Soo Chin Lee, Lingzhi Wang, et al.. (2002). Explaining Interindividual Variability of Docetaxel Pharmacokinetics and Pharmacodynamics in Asians Through Phenotyping and Genotyping Strategies. Journal of Clinical Oncology. 20(17). 3683–3690. 232 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact